Different pharmaceutical preparations of Δ9‐tetrahydrocannabinol differentially affect its behavioral effects in rats
Sign Up to like & getrecommendations! Published in 2019 at "Addiction Biology"
DOI: 10.1111/adb.12745
Abstract: Based on the contribution of the endocannabinoid system to the pathophysiology of schizophrenia, the primary pro‐psychotic ingredient of Cannabis sativa, Δ‐9‐tetrahydrocannabinol (Δ‐9‐THC), is used in preclinical as well as clinical research to mimic schizophrenia‐like symptoms.… read more here.
Keywords: different pharmaceutical; water; lipid based; water based ... See more keywords